Skip to main content
OpenTrials
Completed

NCT Number: NCT01152879

Home Parenteral Nutrition in Cancer Patients

This study is being done to examine the effect of Parenteral (intravenous) nutrition support in the home setting on quality of life in cancer patients. In addition, this study is being done to examine the effect of home parenteral nutrition on the use of pain and anti-nausea medication.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cancer Hyperphagia Neoplasms Pathological Conditions, Signs and Symptoms Signs and Symptoms Signs and Symptoms, Digestive

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Cancer Treatment Centers of America at Southwestern Regional Medical Center

Tulsa, Oklahoma, 74133, United States

About this study

This is a prospective descriptive non-randomized clinical study to examine quality of life outcomes and use of pain and anti-emetic therapy for patients receiving HPN support. The EORTC QLQ-C30 will be used to evaluate quality of life. All subjects will be monitored monthly throughout the course of treatment for a minimum of 3 months and a maximum of 1 year.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with a cancer diagnosis who have been receiving parenteral nutrition in the hospital or have started on HPN while at Cancer Treatment Centers of America and meet the criteria for home parenteral nutrition.
  • Patient expected to have a life expectancy of greater than 90 days post discharge.

Exclusion criteria

  • Patients less than 18 years of age
  • HPN patients who do not receive nutrition assessment and follow-up by the Coram Healthcare nutrition support team
  • Refuse to participate

Treatment and study plan

Home Parenteral Nutrition

Dietary Supplement

Cancer Patients who are discharged on HPN will be monitored for quality of life, nutrition status, pain and nausea medication usage

Other names: Intravenous nutrition

Primary outcomes

  1. Quality of Life

    Time frame: Monthly for a minimum of 3 months to a maximum of 12 months

    To examine the effect of parenteral nutrition support in the home care setting on quality of life as measured by the EORTC QLQ-C30

Secondary outcomes

  1. Pain and nausea medication usage

    Time frame: Monthly for a minumum of 3 months to a maximum of 12 months

    To examine the effect of home parenteral nutrition on the use of pain medication and anti-emetic therapy administered intravenously, subcutaneously, or orally.

Sponsors and collaborators

Lead sponsor

Southwestern Regional Medical Center

Other

Registry information

Official study title

An Evaluation of Quality of Life Outcomes in Cancer Patients Receiving Home Parenteral

Important dates

Study start
2010
Primary completion
2013
Study completion
2013
First posted
Jun 29, 2010
Registry last updated
Feb 21, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.